Skip to main content

Table 2 PD-L1 expression, EBER ISH status with clinic-pathological features of GC patients

From: Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer

Variables EBER ISH status p value
EBER positive (+) EBER negative (−)
Sex    0.003*
 male 82/2504 (3.3%) 1717/2504 (68.6%)  
 female 14/2504 (0.6%) 691/2504 (27.5%)  
Lauren type    0.000*
 Diffuse/mixed 77/2504 (3.1%) 1503/2504 (60%)  
 intestinal 19/2504 (0.8%) 905/2504 (36.1%)  
Differentiation    0.001*
 poorly differentiated 79/2504 (3.1%) 1600/2504 (63.9%)  
 well-moderately 17/2504 (0.7%) 808/2504 (32.3%)  
T stage    0.322
 pT3 + T4 55/2504 (2.2%) 1500/2504 (59.9%)  
 pT1 + T2 41/2504 (1.6%) 908/2504 (36.3%)  
Lymphnode metastasis    0.326
 LNM+ 53/2504 (2.1%) 1450/2504 (57.9%)  
 LNM- 43/2504 (1.7%) 958/2504 (38.3%)  
PD-L1 expression    0.524
 PD-L1 - 52/2358 (2.2%) 1617/2358 (68.6%)  
 PD-L1 > =1% 25/2358 (1.1%) 664/2358 (28.1%)